BACKGROUND: Clopidogrel use after drug-eluting stent (DES) coronary artery implantation is essential for the prevention of early in-stent thrombosis, but clopidogrel use among older DES recipients has not been widely studied. We sought to identify characteristics associated with failure to fill a clopidogrel prescription and to examine the relationship between a clopidogrel prescription fill and hospitalization for acute myocardial infarction (AMI) or death. METHODS AND RESULTS: This study was a retrospective analysis of administrative data (20% sample) of 15 996 Medicare Part D enrollees who received a DES in 2006 to 2007. We modeled the adjusted probability and odds of clopidogrel prescription fill within 7 and 90 days of discharge and its association with AMI hospitalization or death. Of the study sample, 19.7% did not fill a clopidogrel prescription within 7 days of discharge, falling to 13.3% by day 90. The adjusted probability of filling a clopidogrel prescription within 7 or 90 days of discharge was lower for patients with dementia (20.2% less likely; 95% CI, 10.4%-30.1%), depression (10.7% less likely; 95% CI, 6.9%-14.5%), age >84 years compared to age 65 to 69 years (10.6% less likely; 95% CI, 8.6%-12.7%), black race (6.6% less likely; 95% CI, 4.2%-9.0%), intermediate levels of medication cost share (5.2% less likely; 95% CI, 2.9%-7.6%), and female sex (3.3% less likely; 95% CI, 2.1%-4.5%). It was higher for patients initially hospitalized for an AMI (12.5% more likely; 95% CI, 11.3%-13.6%). Failure to fill a clopidogrel prescription within 7 days of discharge was associated with a higher adjusted odds ratio of death during days 8 to 90 (2.44; 95% CI, 1.76-3.38) but was not associated with an increased risk of hospitalization for AMI. CONCLUSIONS: One in 5 patients failed to fill a prescription for clopidogrel at 7 days after DES placement, and 1 in 7 failed to do so by 3 months. Individual characteristics available at the time of hospital discharge were associated with a clopidogrel prescription fill. Those characteristics most strongly associated with nonadherence, including age >84 years, not having an AMI, depression, and dementia, may guide clinicians and health systems seeking to target this high-risk population and improve health outcomes after percutaneous coronary intervention.
BACKGROUND:Clopidogrel use after drug-eluting stent (DES) coronary artery implantation is essential for the prevention of early in-stent thrombosis, but clopidogrel use among older DES recipients has not been widely studied. We sought to identify characteristics associated with failure to fill a clopidogrel prescription and to examine the relationship between a clopidogrel prescription fill and hospitalization for acute myocardial infarction (AMI) or death. METHODS AND RESULTS: This study was a retrospective analysis of administrative data (20% sample) of 15 996 Medicare Part D enrollees who received a DES in 2006 to 2007. We modeled the adjusted probability and odds of clopidogrel prescription fill within 7 and 90 days of discharge and its association with AMI hospitalization or death. Of the study sample, 19.7% did not fill a clopidogrel prescription within 7 days of discharge, falling to 13.3% by day 90. The adjusted probability of filling a clopidogrel prescription within 7 or 90 days of discharge was lower for patients with dementia (20.2% less likely; 95% CI, 10.4%-30.1%), depression (10.7% less likely; 95% CI, 6.9%-14.5%), age >84 years compared to age 65 to 69 years (10.6% less likely; 95% CI, 8.6%-12.7%), black race (6.6% less likely; 95% CI, 4.2%-9.0%), intermediate levels of medication cost share (5.2% less likely; 95% CI, 2.9%-7.6%), and female sex (3.3% less likely; 95% CI, 2.1%-4.5%). It was higher for patients initially hospitalized for an AMI (12.5% more likely; 95% CI, 11.3%-13.6%). Failure to fill a clopidogrel prescription within 7 days of discharge was associated with a higher adjusted odds ratio of death during days 8 to 90 (2.44; 95% CI, 1.76-3.38) but was not associated with an increased risk of hospitalization for AMI. CONCLUSIONS: One in 5 patients failed to fill a prescription for clopidogrel at 7 days after DES placement, and 1 in 7 failed to do so by 3 months. Individual characteristics available at the time of hospital discharge were associated with a clopidogrel prescription fill. Those characteristics most strongly associated with nonadherence, including age >84 years, not having an AMI, depression, and dementia, may guide clinicians and health systems seeking to target this high-risk population and improve health outcomes after percutaneous coronary intervention.
Authors: P Michael Ho; Thomas T Tsai; Tracy Y Wang; Susan M Shetterly; Christina L Clarke; Alan S Go; Art Sedrakyan; John S Rumsfeld; Eric D Peterson; David J Magid Journal: Circ Cardiovasc Qual Outcomes Date: 2010-03-30
Authors: Stefanie Schulz; Tibor Schuster; Julinda Mehilli; Robert A Byrne; Julia Ellert; Steffen Massberg; Julia Goedel; Olga Bruskina; Kurt Ulm; Albert Schömig; Adnan Kastrati Journal: Eur Heart J Date: 2009-07-11 Impact factor: 29.983
Authors: John L Petersen; John J Barron; Bradley G Hammill; Mark J Cziraky; Kevin J Anstrom; Peter M Wahl; Eric L Eisenstein; Mitchell W Krucoff; Robert M Califf; Kevin A Schulman; Lesley H Curtis Journal: Am Heart J Date: 2010-03 Impact factor: 4.749
Authors: Ignacio Ferreira-González; Josep R Marsal; Aida Ribera; Gaietà Permanyer-Miralda; Bruno García-Del Blanco; Gerard Martí; Purificación Cascant; Victoria Martín-Yuste; Salvatore Brugaletta; Manuel Sabaté; Fernando Alfonso; Mari L Capote; Jose M De La Torre; Marta Ruíz-Lera; Dario Sanmiguel; Mérida Cárdenas; Beth Pujol; Jose A Baz; Andrés Iñiguez; Ramiro Trillo; Omar González-Béjar; Juan Casanova; Joaquín Sánchez-Gila; David García-Dorado Journal: Circulation Date: 2010-08-23 Impact factor: 29.690
Authors: Yunjie Song; Jonathan Skinner; Julie Bynum; Jason Sutherland; John E Wennberg; Elliott S Fisher Journal: N Engl J Med Date: 2010-05-12 Impact factor: 91.245
Authors: P Michael Ho; Thomas T Tsai; Thomas M Maddox; J David Powers; Nikki M Carroll; Cynthia Jackevicius; Alan S Go; Karen L Margolis; Terese A DeFor; John S Rumsfeld; David J Magid Journal: Circ Cardiovasc Qual Outcomes Date: 2010-04-20
Authors: Deborah A Levine; Lewis B Morgenstern; Kenneth M Langa; John D Piette; Mary A M Rogers; Sudeep J Karve Journal: Ann Neurol Date: 2013-02-22 Impact factor: 10.422
Authors: O Kenrik Duru; Sarah Edgington; Carol Mangione; Norman Turk; Chi-Hong Tseng; Lindsay Kimbro; Susan Ettner Journal: Pharmacotherapy Date: 2014-10-14 Impact factor: 4.705
Authors: Tara I Chang; Maria E Montez-Rath; Jenny I Shen; Matthew D Solomon; Glenn M Chertow; Wolfgang C Winkelmayer Journal: J Am Heart Assoc Date: 2014-10-21 Impact factor: 5.501
Authors: P Michael Ho; Colin I O'Donnell; Marina McCreight; Anthony A Bavry; Hayden B Bosworth; Saket Girotra; P Michael Grossman; Christian Helfrich; Faisal Latif; David Lu; Michael Matheny; Kreton Mavromatis; Jose Ortiz; Amitabh Parashar; Devona M Ratliff; Gary K Grunwald; Michael Gillette; Hani Jneid Journal: J Am Heart Assoc Date: 2022-06-29 Impact factor: 6.106